Orforglipron 0.5mg x 25 Tablets
+ $9.99 flat-rate shipping
Orforglipron is a non-peptide, orally bioavailable small-molecule GLP-1 receptor agonist. Supplied as 25 oral tablets of 0.5mg for research on oral incretin receptor targeting, glucose regulation, and appetite-pathway studies. Analytical identity and purity confirmed per batch. For in-vitro and laboratory research only.
Incretin-class research compounds that engage GLP-1 and related receptors, widely used in studies of glucose regulation, appetite pathways, and energy metabolism.
Research Applications
Orforglipron is used by qualified researchers to investigate pathways including:
- ◈Incretin-receptor signaling (GLP-1, GIP, glucagon)
- ◈Glucose homeostasis and insulin-secretion studies
- ◈Appetite-regulation and energy-balance models
- ◈Gastric-emptying and satiety-pathway research
Product Specifications
Handling & Reconstitution
Orforglipron is supplied as 0.5mg x 25 tablets. Store at controlled room temperature in the original sealed container, protected from light and moisture. Handle using standard laboratory precautions.
Quality Assurance
Every batch of Orforglipron is analytically verified by an independent third-party laboratory for identity, purity, and potency. Certificates of Analysis are generated per batch and are accessible via the Batch Testing page or the Batch / COA tab above.
Frequently Asked Questions
How is Orforglipron supplied?
Orforglipron is supplied as 0.5mg x 25 tablets in a sealed container. Store at room temperature, protected from moisture and light, until used in research.
What purity does Vial Research guarantee for Orforglipron?
Each batch of Orforglipron is analytically tested by an independent third-party laboratory. Purity is verified to ≥98% (HPLC) for peptide and small-molecule products. A batch-specific Certificate of Analysis (COA) is available on every product page via the Batch / COA tab.
How is Orforglipron stored?
Store tablets/capsules at controlled room temperature in a dry environment, protected from light. Avoid repeated freeze-thaw cycles.
Is Orforglipron intended for human use?
No. Orforglipron is sold for in-vitro and laboratory research use only by qualified researchers. It is not a drug, supplement, or consumer product and has not been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease or condition.
